Immune therapeutic targeting of glioma cancer stem cells

  • Hatiboglu M
  • Wei J
  • Wu A
 et al. 
  • 27


    Mendeley users who have this article in their library.
  • 15


    Citations of this article.


Glioblastoma multiforme (GBM) is a lethal cancer that responds poorly to radiotherapy and chemotherapy. Glioma cancer stem cells (gCSCs) have been shown to recapitulate the characteristic features of GBM and to mediate chemotherapy and radiation resistance. Immunotherapeutic targeting of this cell population holds therapeutic promise but must be considered in the context of the immunosuppressive properties mediated by the gCSC. Recent findings have indicated that this goal will be challenging because the gCSC can suppress both the innate and adaptive immune systems by a variety of gCSC-secreted products and cell-membrane interactions. In this review article, we will attempt to reconcile the disparate research findings regarding the potential of immune targeting of the gCSC and propose several novel solutions.

Author-supplied keywords

  • Glioblastoma multiforme
  • Glioma cancer stem cells
  • Immunotherapy
  • STAT3

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Mustafa Aziz Hatiboglu

  • Jun Wei

  • Adam Sauh Gee Wu

  • Amy B. Heimberger

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free